Sam S. Yoon, MD
Sarcomas and Other Soft Tissue Tumors; Gastric (Stomach) Cancer; Small Bowel Tumors; Neuroendocrine Tumors; Lymphoma and Spleen Tumors; Adrenal Tumors; Melanoma
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Yoon accepts the following list of insurance providers. Select your insurance provider to see more details.
Memorial Sloan Kettering is an in-network provider with Aetna HMO, POS, and PPO plans. Aetna does not include us in any of the plans you can purchase through the insurance exchanges or through Medicare. Please ask your insurance if you need a one-time referral. MSK has an agreement with the Aetna Transplant Program for all Aetna's commercial products.
In New York State
Memorial Sloan Kettering is an in-network provider with Empire Blue Cross Blue Shield (Wellpoint) of New York HMO, EPO, PPO, and POS plans, with the following exceptions:
- Empire Blue Cross Blue Shield does not include us in any of the plans you can buy through the insurance exchanges.
- Memorial Sloan Kettering is not an in-network provider for Empire's Medicare Managed Care plan known as Mediblue).
- Memorial Sloan Kettering is a designated Center of Excellence by Blue Cross Blue Shield.
In New Jersey
Memorial Sloan Kettering is an in-network provider with some Horizon Blue Cross Blue Shield of New Jersey plans for individuals, families, and small businesses. For example, the PPO plan is in-network with our Manhattan locations.
Horizon Blue Cross HMO is only in-network with our Basking Ridge, Bergen and Monmouth locations. It does not allow access to our Manhattan facilities.
Horizon Blue Cross PPO is in network with our Basking Ridge, Bergen, Monmouth and Manhattan locations.
OMNIA Plans: Tier I EPO based plan policy is only in-network with our Basking Ridge, Bergen and Monmouth locations and does not allow access to our Manhattan sites. Tier II EPO is only in-network with our Manhattan sites if it is a blue-card plan (there would be a suitcase logo indicating PPO on the front of the card).
Other plans may only be in-network at our Basking Ridge, Bergen or Monmouth locations.
Outside New York State and New Jersey
Some, but not all, Blue Cross Blue Shield plans outside of New York and New Jersey include Memorial Sloan Kettering as an in-network provider. Contact your insurance to find out if your plan provides in-network access to Memorial Sloan Kettering.
We understand that there may be many complexities involved with insurance coverage purchased through the health exchange network of the Affordable Care Act. We’re here to help. If you have questions about how your care will be covered by an insurance provider, or need help navigating a change in coverage, please call us at 646-227-3378; if you are not a resident of New York, you can call us at 866-248-1274. Our team is here to listen to your concerns and assist you in any way we can. We want our care to be as accessible and affordable for as many people as possible.
Memorial Sloan Kettering is an in-network provider with CIGNA's HMO, POS, and PPO plans. CIGNA does not include us in any of the plans you can buy through the insurance exchanges.
- If you are a New York State resident: Please ask your insurance if you need a one-time referral.
- If you live outside of New York State: Please ask your insurance if you have in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with EmblemHealth’s PPO, EPO, POS, HMO plans and Medicare plans. Emblem Health does not include us in any of its Select Care network plans. EmblemHealth includes GHI, HIP, Vytra, and ConnecticCare (in NYS Only). You must bring a referral from your Emblem primary care doctor to your first appointment.
Formerly known as Health Plus Amerigroup, Empire Blue Cross Blue Shield Health Plus is an in-network provider with Memorial Sloan Kettering. You will need a one-time referral from your primary care doctor.
Memorial Sloan Kettering is an in-network provider with HealthFirst’s commercial products; these commercial products are not purchased on the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with HealthSmart’s Accel, HSPC, and HPO networks.
Memorial Sloan Kettering is a designated Center of Excellence by Humana.
Memorial Sloan Kettering is a designated Center of Excellence by Interlink Health Services.
Memorial Sloan Kettering is a designated Center of Excellence by Lifetrac.
Memorial Sloan Kettering is an in-network provider for all MagnaCare health plans except those products you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with Medicaid NY Empire Blue Cross Blue Shield HealthPlus (formerly known as Amerigroup). You will need a one-time referral from your primary care doctor.
In New York: Memorial Sloan Kettering’s New York locations are in-network with the Emblem
In New Jersey: Memorial Sloan Kettering’s New Jersey locations in Basking Ridge, Bergen and Monmouth are in-network with the Horizon Medicare Advantage Plan. This plan is not accepted for care provided at MSK’s New York locations.
If you are enrolled in any other Medicare Advantage plan, please contact your insurance carrier to determine your benefits and coverage at Memorial Sloan Kettering since your access may be limited.
Memorial Sloan Kettering is an in-network provider with some Multiplan/Beech Street/PHCS plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is a designated Center of Excellence by Multiplan.
If you are covered by more than one insurance plan, you will want to determine your benefits from both plans. First, you need to determine which one is your primary insurance provider by contacting your employee benefits office or your insurance carriers. After you find out which is your primary insurance provider, you should then contact your insurance carrier to determine if you have access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with some MVP plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider for New York State employees who have enrolled in UnitedHealthcare's Cancer Resource Services. If you have the Empire Plan, you should call Cancer Resources Services at 866-936-6002 to verify and enroll in this coverage.
Memorial Sloan Kettering is in-network with Oscar’s Circle Plus Network, a part of its Small Group Broad line that is offered only to select small business groups. Oscar does not include Memorial Sloan Kettering as an in-network provider for any of its individual plans. Please confirm eligibility with your insurance carrier.
We have agreements with several insurance companies that may provide additional coverage for cancer patients. These benefit programs include:
- AXA Assistance USA
- Beech Street
- Integrated Health Plans
- National Health Administrators
- National Preferred Provider Network
- UnitedHealthcare's Cancer Resource Services
- United Resource Network
- Veterans Choice Program
Memorial Sloan Kettering is an in-network provider with Oxford’s Freedom and Liberty plans as well as the Metro Plan (which is only offered to small business groups and no longer offered as individual plans). Please confirm with your insurance if you need a one-time referral. Note: Oxford’s Medicare Managed Care plan — Secure Horizon — does not include Memorial Sloan Kettering as an in-network provider. Oxford does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with the World Trade Center Health Program.
Memorial Sloan Kettering is an in-network provider with QualCare's PPO and HMO/POS network.
Memorial Sloan Kettering is a designated Center of Excellence by Specialty Care Management.
Hospital and physician services may be covered by TRICARE. Please call your TRICARE plan to confirm coverage at Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with UnitedHealthCare's HMO, POS, and PPO plans. Please confirm with your insurance if a one-time referral is needed.
UnitedHealthCare's Medicare Managed Care plan does not include Memorial Sloan Kettering as an in-network provider.
United does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is a designated Center of Excellence by UnitedHealthcare.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.
MD, University of California San Diego
General Surgery - Massachusetts General Hospital
Surgical Oncology - Memorial Sloan Kettering Cancer Center
I am a surgical oncologist who specializes in caring for people with stomach (gastric) cancer and gastroesophageal junction (GEJ) tumors, sarcomas, and soft-tissue tumors. I also have expertise in treating patients with tumors of the duodenum, small intestine, adrenal gland, neuroendocrine system, spleen, and lymph nodes. I work primarily at Memorial Sloan Kettering’s Manhattan location but also see patients at Memorial Sloan Kettering Basking Ridge and MSK Monmouth in New Jersey.
My main goal is to provide each patient with the absolute best care for his or her particular disease. I work closely with medical oncologists, radiation oncologists, pathologists, and other medical professionals who specialize in the diagnosis and treatment of patients with gastric/gastroesophageal junction cancer and sarcomas. I feel it’s important, even for experienced surgeons, to constantly improve and expand one’s surgical skills. For me, this has involved early adoption of new laparoscopic and minimally invasive techniques, such as robot-assisted resection of gastric, adrenal, and other intra-abdominal tumors. I’ve performed over 100 minimally invasive robot-assisted procedures using the da Vinci Surgical System, which allows for smaller incisions, more precise operations, and faster recovery.
I have performed clinical and laboratory research throughout my career and am the author of more than 150 peer-reviewed articles, reviews, and book chapters. Many of these publications describe the treatment and outcome of patients with various sarcomas (e.g. retroperitoneal and pelvic sarcomas, extremity and trunk sarcomas, and angiosarcomas) and gastrointestinal cancers (e.g. gastric adenocarcinoma, hereditary diffuse gastric cancer syndrome, gastrointestinal stromal tumors, and colorectal cancer liver metastases). I am on the editorial board of medical journals, such as the Annals of Surgical Oncology and the Journal of Gastrointestinal Surgery and serve on several national committees, including the American Joint Commission on Cancer Soft Tissue Sarcoma Expert Panel.
I am the principal investigator for a research laboratory that examines the role of tumor blood vessels and cancer stem cells in controlling the growth, spread, and treatment response of gastric cancers and sarcomas. My laboratory is currently funded by an R01 grant from the National Cancer Institute as well as other foundation and society grants. We previously completed a clinical trial examining the role of bevacizumab (Avastin®), a drug that inhibits vascular endothelial growth factor A (VEGF-A), and radiation in the pre-operative treatment of resectable sarcomas. Bevacizumab markedly improved the tumor-killing effects of radiation, and this trial served as the basis for an ongoing multi-institutional trial of VEGF-A inhibition and radiation run by the Children’s Oncology Group and the Radiation Therapy Oncology Group. More recently, we have found that inhibiting cancer stem cells improves the effectiveness of standard chemotherapies, and we are currently developing clinical trials in this area.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Selected Book Chapters
“Surgical management of metastatic colon and rectal cancer.” Yoon SS, Tanabe KK. In: American Cancer Society Atlas of Clinical Oncology: Cancer of the Lower Gastrointestinal Tract. Steele GD, Phillips TL, Chabner BA, eds. Willet C, series ed. Hamilton, Ontario, CA: BC Decker Inc., 2001; 170-195.
“Surgical and regional therapy for liver metastases.” Tanabe KK, Yoon SS. In: Oncology: An Evidence Based Approach. Chang AE, Ganz PA, Hayes DF, Kinsella TJ, Pass HI, Schiller JH, Stone RM, Strecher VJ, eds. New York: Springer-Verlag, 2006; 1636-1654.
“Benign liver tumors.” Yoon SS, Tanabe KK. In: Advanced Therapy in Surgical Oncology. Pollock RE, Curley SA, Ross MI, Perrior ND, eds. Hamilton, British Columbia: Decker, 2007; 131-142.
“Soft tissue sarcomas.” DeLaney TF, Hornicek FJ, Kirsch DG, Yoon SS, Rosenberg AE, Harmon DC, Mankin HJ, Rosenthal D, Suit HD. In: Treatment of Cancer. Price P, Sikora K, Illidge T, eds. Oxford, UK: Oxford University Press, 2008.
“Soft tissue and bone sarcomas.” Yoon SS, Hornicek FJ, Harmon DC, DeLaney TF. In: Harrison’s Handbook of Medical Oncology. Chabner BA, Lynch TJ, Longo DL, eds. New York: McGraw Hill, 2008; 549-566.
“Hereditary diffuse gastric cancer.” Pandalai PK, Yoon SS. In: Principles of Clinical Cancer Genetics. Chung DC, Haber DA, eds. New York: Springer, 2010; 97-107.
“The management of soft tissue sarcoma.” Yoon SS, Hornicek FJ. In: Current Surgical Therapy. 10th ed. Cameron JL, Cameron AM, eds. Philadelphia: Elsevier, 2011; 631-636.
“Radiation therapy for desmoid tumors.” El Halabi HO, Chen YL, Mullen JT, Yoon SS, Hornicek FJ, DeLaney TF. In: Desmoid Tumors. Litchman CD, ed. New York: Springer, 2012; 105-126.
“Soft tissue and bone sarcomas.” Yoon SS, Hornicek FJ, Choy E, DeLaney TF. In: Harrison’s Handbook of Medical Oncology. 2nd ed. Chabner BA, Lynch TJ, Longo DL, eds. New York: McGraw Hill (in press).
“The management of gastric adenocarcinoma.” Yoon SS. In: Current Surgical Therapy, 11th ed. Cameron JL, Cameron AM. Philadelphia: Elsevier (in press).
Visit PubMed for a full listing of Dr. Yoon’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Sam S. Yoon discloses the following relationships and financial interests:
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.